Workflow
广发价值核心A
icon
Search documents
广发基金旗下103只产品荣获五星评级
本报讯 (记者昌校宇)作为独立客观公正的第三方专业研究机构,各类基金评级机构评选出的五星基 金,一直是投资者挑选产品的重要指标。基金公司旗下五星基金的数量及其分布也是衡量基金管理人综 合投研能力的重要参考。 近期,晨星(中国)基金研究中心、中国银河证券、招商证券、国泰海通证券、上海证券、天相投顾、 济安金信基金研究中心等7家权威评级机构陆续发布最新基金评级报告,广发基金旗下103只(仅统计主 份额,下同)产品获得五星评级。凭借多年积淀的平台型投研实力和多元化产品布局,广发基金在主动 权益、固定收益、被动指数、海外投资、多资产配置等领域均有"五星闪耀"。 本次最新发布的评级数据显示,广发基金旗下五星基金近半数为主动权益产品,这些绩优基金风格多 样、特点鲜明。例如,在"A+H"全市场选股的产品中,广发价值核心A近年来精准把握新消费、互联网 科技行情,获得中国银河证券、招商证券、国泰海通证券、天相投顾、上海证券和济安金信基金研究中 心等6家机构的三年期五星基金评级。行业主题方面,广发基金在北交所、大制造、TMT、医药等板块 均有表现突出的代表产品。例如,广发北交所精选两年定开A获评招商证券、天相投顾三年期五星评 级 ...
上半年涨幅最高的题材基金:创新药、北交所
Sou Hu Cai Jing· 2025-08-12 04:28
Group 1 - The core viewpoint of the article highlights that funds focused on innovative pharmaceuticals have seen significant gains, with some funds increasing over 61% in the first half of the year [1] - The top-performing funds include several that are primarily invested in innovative drugs, with the highest return being 86.48% for the fund "汇添富音港优势精选A" [1] - Other notable funds in the top 16 also show strong performance, with returns ranging from 61.77% to 83.15% [1] Group 2 - The article suggests that innovative drugs can be pursued when the market declines, indicating a potential buying opportunity [2] - The "广发成长领航一年持有A" fund has a significant portion of its holdings in new consumer concepts, with major investments in companies like 泡泡玛特 and 老铺黄金 [3] - The fund manager 吴远怡 has demonstrated strong performance across various products, with most showing commendable returns [4] Group 3 - The historical performance of the "广发科技创新" fund shows a maximum drawdown of -53%, indicating high volatility [5] - Overall, the funds discussed are characterized by high volatility and significant drawdowns, making them more suitable for investors willing to buy during market dips [7] - The article emphasizes that these funds may not be suitable for low-risk investors due to their performance characteristics [7]